Comparative efficacy of fenofibrate/pravastatin/ezetimibe and simvastatin/ezetimibe therapies in type 2 diabetic patients with combined hyperlipidaemia and cardiovascular disease

被引:0
|
作者
Farnier, M. [1 ]
Steinmetz, A. [2 ]
Csaszar, A. [3 ]
Retterstol, K. [4 ]
Dluzniewski, M. [5 ]
机构
[1] Point Med, Dijon, France
[2] St Nikolaus Stiftshosp GmbH, Andernach, Germany
[3] State Hlth Ctr, Budapest, Hungary
[4] Oslo Univ Hosp Rikshosp, Oslo, Norway
[5] Warsaw Hosp, Warsaw, Poland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1296
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Ezetimibe/Simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: The VYTAL study
    Goldberg, Ronald B.
    Guyton, John R.
    Mazzone, Theodore
    Md, RutH'S. Weinstock
    Polis, Adam
    Edwards, Patricia
    Tomassini, Joanne E.
    Tershakovec, Andrew M.
    MAYO CLINIC PROCEEDINGS, 2006, 81 (12) : 1579 - 1588
  • [32] Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes A prospective randomized double-blind clinical trial
    Ruggenenti, Piero
    Cattaneo, Dario
    Rota, Stefano
    Iliev, Ilian
    Parvanova, Aneliya
    Diadei, Olimpia
    Ene-Iordache, Bogdan
    Ferrari, Silvia
    Bossi, Antonio C.
    Trevisan, Roberto
    Belviso, Antonio
    Remuzzi, Giuseppe
    DIABETES CARE, 2010, 33 (09) : 1954 - 1956
  • [33] Evaluation of ezetimibe/simvastatin versus rosuvastatin in hypercholesterolemic patients with type 2 diabetes or metabolic syndrome
    Ballantyne, Christie M.
    Davidson, Michael H.
    Catapano, Alberico L.
    Brady, William E.
    Gazzara, Russell A.
    Tershakovec, Andrew
    DIABETES, 2006, 55 : A520 - A520
  • [34] Relationships Between Metabolic Syndrome and Other Baseline Factors and the Efficacy of Ezetimibe/Simvastatin and Atorvastatin in Patients With Type 2 Diabetes and Hypercholesterolemia
    Goldberg, Ronald B.
    Guyton, John R.
    Mazzone, Theodore
    Weinstock, Ruth S.
    Polis, Adam B.
    Tipping, Diane
    Tomassini, Joanne E.
    Tershakovec, Andrew M.
    DIABETES CARE, 2010, 33 (05) : 1021 - 1024
  • [35] No effect of lipid lowering by simvastatin or simvastatin and ezetimibe on platelet function in patients with type 2 diabetes or impaired glucose tolerance and coronary artery disease
    Malmstroem, Rickard E.
    Settergren, Magnus
    Boehm, Felix
    Ryden, Lars
    Pernow, John
    Hjemdahl, Paul
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E80 - E81
  • [36] Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia
    Iovine, C.
    Lilli, S.
    Gentile, A.
    Patti, L.
    Di Marino, L.
    Cipriano, P.
    Riccardi, G.
    Rivellese, A. A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (08) : 560 - 565
  • [37] Efficacy of ezetimibe combined with atorvastatin in the treatment of carotid artery plaque in patients with type 2 diabetes mellitus complicated with coronary heart disease
    Wang, Jing
    Ai, Xiao-Bo
    Wang, Fei
    Zou, Yao-Wu
    Li, Li
    Yi, Xiao-Lei
    INTERNATIONAL ANGIOLOGY, 2017, 36 (05) : 467 - 473
  • [38] Safety and efficacy of moderate-intensity statin with ezetimibe in elderly patients with atherosclerotic cardiovascular disease
    Cha, Jung-Joon
    Kim, Ju Hyeon
    Hong, Soon Jun
    Lim, Subin
    Joo, Hyung Joon
    Park, Jae Hyoung
    Yu, Cheol Woong
    Lee, Pil Hyung
    Lee, Seung Whan
    Lee, Cheol Whan
    Moon, Jae Youn
    Lee, Jong-Young
    Kim, Jung-Sun
    Park, Jae Suk
    Lim, Do-Sun
    JOURNAL OF INTERNAL MEDICINE, 2025, 297 (04) : 400 - 408
  • [39] Effect of demographic and baseline lipid/metabolic factors on the efficacy of ezetimibe/simvastatin (E/S) and atorvastatin (A) therapies in type 2 diabetes (T2DM) patients with hypercholesterolemia (HC)
    Goldberg, Ronald B.
    Guyton, John R.
    Mazzone, Theodore
    Weinstock, Ruth S.
    Polis, Adam
    Tomas, Joanne E.
    Tershakovec, Andrew M.
    DIABETES, 2008, 57 : A250 - A251
  • [40] Efficacy of ezetimibe/simvastatin 10/20 and 10/40 mg compared with atorvastatin 20 mg in patients with type 2 diabetes mellitus
    Constance, C.
    Westphal, S.
    Chung, N.
    Lund, M.
    McCrary Sisk, C.
    Johnson-Levonas, A. O.
    Massaad, R.
    Allen, C.
    DIABETES OBESITY & METABOLISM, 2007, 9 (04): : 575 - 584